The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer

被引：5
作者：
Pharaon, Rebecca R. [1 ]
Xing, Yan [1 ]
Agulnik, Mark [1 ]
Villaflor, Victoria M. [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
immunotherapy; head and neck cancer; oropharyngeal squamous cell carcinoma; nasopharyngeal carcinoma; viral-associated cancers; human papillomavirus; Epstein-Barr virus; SQUAMOUS-CELL CARCINOMA; EPSTEIN-BARR-VIRUS; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS; NASOPHARYNGEAL CARCINOMA; OPEN-LABEL; OROPHARYNGEAL CANCER; ANTITUMOR-ACTIVITY; METASTATIC HEAD; PLUS CETUXIMAB;
D O I：
10.3389/fonc.2021.649963
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A subset of head and neck cancers arising in the oropharynx and the nasopharynx are associated with human papillomavirus or Epstein-Barr virus. Unfortunately, limited treatment options exist once patients develop recurrent or metastatic disease in these cancers. Interest has risen in utilizing novel strategies including combination immune checkpoint inhibitors, vaccines, and adoptive cellular therapy, to improve treatment response and outcomes. Several ongoing studies are investigating the potential to overcome resistance to standard of care chemoradiation therapy with monotherapy or combination immunotherapy strategies in these viral-associated head and neck cancers.
引用
收藏
页数：12
相关论文
共 50 条
  • [31] Immunotherapy for head and neck cancer
    Wu, Annie A.
    Niparko, Kevin J.
    Pai, Sara I.
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2008, 15 (03) : 275 - 289
  • [32] Immunotherapy for head and neck cancer: Recent advances and future directions
    Cramer, John D.
    Burtness, Barbara
    Ferris, Robert L.
    [J]. ORAL ONCOLOGY, 2019, 99
  • [33] Immunotherapy in head and neck cancer: Harnessing profit on a system disruption
    Rancoule, Chloe
    Vallard, Alexis
    Espenel, Sophie
    Guy, Jean-Baptiste
    Xia, Yaoxiong
    Hamrouni, Anis El Meddeb
    Rodriguez-Lafrasse, Claire
    Chargari, Cyrus
    Deutsch, Eric
    Magne, Nicolas
    [J]. ORAL ONCOLOGY, 2016, 62 : 153 - 162
  • [34] Immunotherapy for head and neck cancer
    Davidson, H. Carter
    Leibowitz, Michael S.
    Lopez-Albaitero, Andres
    Ferris, Robert L.
    [J]. ORAL ONCOLOGY, 2009, 45 (09) : 747 - 751
  • [35] Immunotherapy in Head and Neck Squamous Cell Cancer
    Denaro, Nerina
    Merlano, Marco Carlo
    [J]. CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2018, 11 (04) : 217 - 223
  • [36] Immunotherapy for head and neck cancer: advances and deficiencies
    De Costa, Anna-Maria
    Young, M. Rita I.
    [J]. ANTI-CANCER DRUGS, 2011, 22 (07) : 674 - 681
  • [37] Current Role of Dacomitinib in Head and Neck Cancer
    Elicin, Olgun
    Ozsahin, Mahmut
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (06) : 735 - 742
  • [38] Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
    Cyberski, Thomas F.
    Singh, Alka
    Korzinkin, Michael
    Mishra, Vasudha
    Pun, Frank
    Shen, Le
    Wing, Claudia
    Cheng, Xiangying
    Baird, Brandon
    Miao, Yuxuan
    Elkabets, Moshe
    Kochanny, Sara
    Guo, Wenji
    Dyer, Emma
    Pearson, Alexander T.
    Juloori, Aditya
    Lingen, Mark
    Cole, Grayson
    Zhavoronkov, Alex
    Agrawal, Nishant
    Izumchenko, Evgeny
    Rosenberg, Ari J.
    [J]. NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [39] Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review
    Hui, Caressa
    Chau, Brittney
    Gan, Greg
    Stokes, William
    Karam, Sana D.
    Amini, Arya
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Immune Landscape and Role of Immunotherapy in Treatment of HPV-Associated Head and Neck Squamous Cell Carcinoma (HNSCC)
    Turbeville, Hannah R.
    Toni, Tiffany A.
    Allen, Clint
    [J]. CURRENT OTORHINOLARYNGOLOGY REPORTS, 2022, 10 (01) : 96 - 107
12345